Seguridad del Paciente - Patient Safety

Ministerio de Sanidad, Servicios Sociales e Igualdad

logo
EspañolEnglish
You are here:   Home Information Newsletters Orally administered Methrotexate: severe adverse reactions derived from mistakes on the appropriate dosage
large small default
Orally administered Methrotexate: severe adverse reactions derived from mistakes on the appropriate dosage PDF Print E-mail

The Spanish Agency of Drugs and Medical Products informs healthcare professionals and patients on the errors committed in the dosages of orally administered methrotexate.

Link: Informative notes on drugs intended for human consumption/ safety/ 2011/ July 13th

Last Updated on Thursday, 11 August 2011 12:50